Irene Perlich serves as Executive at NGM BIOPHARMACEUTICALS INC, where they oversee executive responsibilities. Since joining the company, Irene Perlich has executed 2 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Apr 5, 2024 involved transacting 6,284 shares valued at $0.
Irene Perlich currently holds 8,975 shares of NGM BIOPHARMACEUTICALS INC (NGM), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Irene Perlich has been a net neutral trader of NGM stock. They have purchased $0 and sold $0 worth of shares.
Irene Perlich's most recent insider trade was on Apr 5, 2024, when they sold 6,284 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $1.34 |
| Discretionary |